Rijksinstituut voor Volksgezondheid en Milieu
COVID-19 vaccine effectiveness against symptomatic infection with SARS-CoV-2 BA.1/BA.2 lineages among adults and adolescents in a multicentre primary care study, Europe, December 2021 to June 2022 | RIVM
Bron:
rivm.nl